SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-077852
Filing Date
2022-03-17
Accepted
2022-03-17 07:54:56
Documents
13
Period of Report
2022-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d295785d8k.htm   iXBRL 8-K 23530
2 EX-99.1 d295785dex991.htm EX-99.1 58593
  Complete submission text file 0001193125-22-077852.txt   221372

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avro-20220317.xsd EX-101.SCH 2858
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20220317_lab.xml EX-101.LAB 19502
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20220317_pre.xml EX-101.PRE 12158
7 EXTRACTED XBRL INSTANCE DOCUMENT d295785d8k_htm.xml XML 3587
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 22746794
SIC: 2836 Biological Products, (No Diagnostic Substances)